"Citron's reports are a lot more fun to read than just about anything published by a mainstream Wall Street stock analyst."
-- Bloomberg News

Nov. 14, 2015
HomeReportsArchivesContact Us / SuggestionsLegal DisclaimerWho is Citron

Citron Comments on Questcor’s Non-Responsive Response

Posted in Citron Reports by Stocklemon on the February 28th, 2014

Yesterday, Citron published independent laboratory findings on the active ingredient in Questcor's only drug, Acthar Gel.  Today the company's only response to these findings has now been quoted in Bloomberg.

Citron is astonished at what they didn't say.

Click Here to Read our Comments on the Company's Response


5 queries in 0.152 seconds